Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-blined, Placebo Parallel Controlled Phase III Clinical Trial to Evaluate the Effect of Injectable Neucardin on the Mortality of Subjects With Chronic Systolic Heart Failure on Standard HF Therapy.

NCT03388593 is registered in ClinicalTrials.gov with Zensun Sci. & Tech. Co., Ltd. as lead sponsor.

NCT NCT03388593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03388593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-blined, Placebo Parallel Controlled Phase III Clinical Trial to Evaluate the Effect of Injectable Neucardin on the Mortality of Subjects With Chronic Systolic Heart Failure on Standard HF Therapy.
Lead sponsor
Zensun Sci. & Tech. Co., Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
July 23, 2018
Completion date
February 28, 2026
Enrollment
1,600 (estimated)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure